CRP and major depressive disorder: Despite evidence of low dopamine function in MDD [29–31] and preferential response to dopaminergic antidepressants in MDD patients with higher levels of CRP [22], whether alterations in reward circuits in MDD patients with higher inflammation and symptoms of anhedonia involve dopaminergic mechanisms and may respond to relevant therapies is currently unknown.